U.S. Markets closed

Cara: 3Q Earnings Snapshot

STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Tuesday reported a loss of $32.8 million in its third quarter.

The Stamford, Connecticut-based company said it had a loss of 74 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The biotechnology company posted revenue of $5.8 million in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $5.6 million.

Cara shares have increased 60% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $20.74, a climb of 6% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA